Olopatadine combination more effective than loratadine monotherapy in allergic conjunctivitis Nov. 27, 1998
CytoTherapeutics receives patent protection for ocular delivery of therapeutic substances Nov. 25, 1998
First marketing approval granted for Vitrase in Mexico; U.S. phase III trials now under way Nov. 24, 1998
Significant antiinflammatory activity seen with loteprednol etabonate in cataract surgery setting Nov. 5, 1998
RSS